Literature DB >> 16210861

Are the asthma guideline goals achieved in daily practice? A population-based study on treatment adequacy and the control of asthma.

Roberto de Marco1, Lucia Cazzoletti, Isa Cerveri, Angelo Corsico, Massimiliano Bugiani, Simone Accordini, Laura Carrozzi, Rossano Dallari, Aldo De Togni, Alessandra Marinoni, Pietro Pirina, Christer Janson.   

Abstract

BACKGROUND: The guidelines for asthma recommend that the use of anti-inflammatory therapy should be adapted to the severity of the disease. However, few data are available to assess the adequacy of the use of drugs and its influence on the control of asthma in 'real life'.
METHODS: The adequacy of the current use of anti-asthmatic medication according to the Global Initiative for Asthma (GINA) guidelines was assessed in a random sample of 400 asthmatics identified in the frame of the Italian Study on Asthma in Young Adults. Asthma severity was assessed using the GINA criteria; accordingly, a patient was classified as receiving inadequate treatment if his/her current use of drugs was lower than that suggested by the guidelines for the corresponding severity level. The absence of asthma attacks in the last 3 months was used as an indicator of the disease control.
RESULTS: Fifty-five percent of the patients had persistent asthma. Overall, 48% (95% CI 41.2-54.8) of persistent asthmatics were receiving inadequate treatment, and 66% (95% CI 59.5-72.4) had not used their medication daily over the past 3 months. Persistent asthmatics who were inadequately treated had a significantly greater frequency of asthma attacks (geometric mean ratio 3.7; 95% CI 2.1-6.6) than those using an adequate dose of medication. Mild and moderate persistent asthmatics using an adequate medication regimen reported a low number of asthma attacks (median 0). At the multivariate analysis, a good control of the disease was positively associated with an adequate dose of anti-inflammatory medication (OR = 2.2; 95% CI 1.1-4.5) and was negatively associated with a later onset of asthma (OR = 0.96; 95% CI 0.93-0.99) and severe asthma (OR = 0.37; 95% CI 0.17-0.81).
CONCLUSIONS: Despite the increase in the use of inhaled corticosteroids, half of the persistent asthmatics from the general population are using a medication regimen below their severity level. When the use of drugs follows the GINA guideline recommendations, a good control of asthma is also achievable in the daily management of the disease, particularly in the case of mild and moderate asthmatics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16210861     DOI: 10.1159/000088723

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  12 in total

1.  Factors associated with the appropriate use of asthma drugs.

Authors:  Marie-Sophie Jobin; Jocelyne Moisan; Yves Bolduc; Eileen Dorval; Louis-Philippe Boulet; Jean-Pierre Grégoire
Journal:  Can Respir J       Date:  2011 Mar-Apr       Impact factor: 2.409

2.  From the Global Initiative for Asthma report and asthma guidelines to real-life asthma control: is there room for improvement?

Authors:  Elio Novembre; Mattia Giovannini; Simona Barni; Francesca Mori
Journal:  Ital J Pediatr       Date:  2022-07-05       Impact factor: 3.288

3.  Tracing uncontrolled asthma in family practice using a mailed asthma control questionnaire.

Authors:  Lotte van den Nieuwenhof; Tjard Schermer; Marianne Heins; Joke Grootens; Petra Eysink; Ben Bottema; Chris van Weel; Patrick Bindels
Journal:  Ann Fam Med       Date:  2008 Jan-Feb       Impact factor: 5.166

Review 4.  Uncontrolled Asthma: Unmet Needs in the Management of Patients.

Authors:  Marco Caminati; Rachele Vaia; Fabiana Furci; Gabriella Guarnieri; Gianenrico Senna
Journal:  J Asthma Allergy       Date:  2021-05-03

5.  The course of asthma in young adults: a population-based nine-year follow-up on asthma remission and control.

Authors:  Lucia Cazzoletti; Angelo Guido Corsico; Federica Albicini; Eti Maria Giulia Di Vincenzo; Erica Gini; Amelia Grosso; Vanessa Ronzoni; Massimiliano Bugiani; Pietro Pirina; Isa Cerveri
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

Review 6.  Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD.

Authors:  Nicola Scichilone; Alida Benfante; Luca Morandi; Federico Bellini; Alberto Papi
Journal:  Patient Relat Outcome Meas       Date:  2014-11-27

7.  Optimal control of asthma improved eosinophilic otitis media.

Authors:  Yukako Seo; Manabu Nonaka; Yukie Yamamura; Ruby Pawankar; Etsuko Tagaya
Journal:  Asia Pac Allergy       Date:  2018-01-24

8.  Assessment of asthma severity in adults with ever asthma: A continuous score.

Authors:  Lucia Calciano; Angelo Guido Corsico; Pietro Pirina; Giulia Trucco; Deborah Jarvis; Christer Janson; Simone Accordini
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240

9.  Patient perspectives in the management of asthma: improving patient outcomes through critical selection of treatment options.

Authors:  Nicola Scichilone; Adele Contino; Giovanni Battista Figlioli; Giuseppe Paglino; Vincenzo Bellia
Journal:  Patient Prefer Adherence       Date:  2010-02-04       Impact factor: 2.711

10.  Determinants of uncontrolled asthma in a Swedish asthma population: cross-sectional observational study.

Authors:  Mary Kämpe; Karin Lisspers; Björn Ställberg; Josefin Sundh; Scott Montgomery; Christer Janson
Journal:  Eur Clin Respir J       Date:  2014-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.